# Matthias Schmid

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matthias-schmid/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,893 |
| Field | Statistical Methods and Inference |
| h-index | 62 |
| i10-index | 279 |
| Last Known Institution | Zimmer Biomet (Netherlands) |
| OpenAlex ID | https://openalex.org/A5031620559 |
| ORCID iD | https://orcid.org/0000-0002-0788-0317 |
| Works | 687 |

## Researcher papers

- [Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial](https://scholariq.org/papers/lomustine-temozolomide-combination-therapy-versus-standard-temozolomide-therapy/)
- [Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS](https://scholariq.org/papers/plasma-extracellular-vesicle-tau-and-tdp-43-as-diagnostic-biomarkers-in-ftd-and/)

## Researcher topics

- [Statistical Methods and Inference](https://scholariq.org/topics/statistical-methods-and-inference/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Statistical Methods and Bayesian Inference](https://scholariq.org/topics/statistical-methods-and-bayesian-inference/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

## Researcher university

- [Zimmer Biomet (Netherlands)](https://scholariq.org/institutions/zimmer-biomet-netherlands/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.